Inactive Instrument

Farmaceutica Remedia SA Stock CINNOBER BOAT

0M8I

RORMAHACNOR2

Valuation: Farmaceutica Remedia SA

Market Cap	82.27M 17.87M 15.72M 14.6M 13.43M 25.18M 1.73B 25.63M 175M 68.1M 844M 67.09M 65.64M 2.93B	P/E 2024	9.05x	P/E 2025	9.5x
Enterprise Value	25.08M 5.45M 4.79M 4.45M 4.09M 7.68M 528M 7.82M 53.23M 20.76M 257M 20.45M 20.01M 893M	EV / Sales 2024	0.02x	EV / Sales 2025	0.02x
Free-Float	19.13%	Yield 2024	6.06%	Yield 2025	6.25%

* Estimated data More valuation ratios

Latest news : Farmaceutica Remedia SA

05-20	Farmaceutica REMEDIA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-25	Farmaceutica REMEDIA S.A. announces Annual dividend, payable on September 30, 2026	CI
02-25	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-17	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
27/08/25	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
14/05/25	Farmaceutica REMEDIA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
20/03/25	Farmaceutica REMEDIA S.A. announces Annual dividend, payable on September 30, 2025	CI
26/02/25	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/11/24	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
29/08/24	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
13/05/24	Farmaceutica REMEDIA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
27/02/24	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
13/11/23	Farmaceutica REMEDIA S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

More news

Press Releases: Farmaceutica Remedia SA

05-05	Farmaceutica REMEDIA S A : Decision no. 96 of 29.04.2026 O.G.M.S.	PU
04-02	Farmaceutica REMEDIA S A : Convening O.G.M.S. 29/30 April 2026	PU
04-02	Farmaceutica REMEDIA S A : Decision no. 94 of 19.03.2026 E.G.M.S.	PU
02-19	Farmaceutica REMEDIA S A : DECISION 95 (project) – EGMS 19/20.03.2026	PU
02-19	Farmaceutica REMEDIA S A : DECISION 94 (project) – EGMS 19/20.03.2026	PU

More press releases

Managers and Directors: Farmaceutica Remedia SA

Manager	Title	Age	Since
Valentin-Norbert Tarus CEO	Chief Executive Officer	74	01/01/2019
Elena Codrean DFI	Director of Finance/CFO	43	01/11/2006
Cristian Popa CTO	Chief Tech/Sci/R&D Officer	51	01/01/2001

Director	Title	Age	Since
Valentin-Norbert Tarus CHM	Chairman	74	12/03/2007
Elena Codrean BRD	Director/Board Member	43	01/12/2020
Cristian Plocon BRD	Director/Board Member	49	01/05/2023

More insiders

Retail - Drugs without Grocery

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FARMACEUTICA REMEDIA SA	-.--%	-.--%	-	-	17.87M
RAIA DROGASIL S.A.	-0.55%	-1.78%	+30.94%	-35.19%	6.25B
AIN HOLDINGS INC.	+0.48%	+0.24%	-0.46%	+15.96%	1.25B
QOL HOLDINGS CO., LTD.	+0.43%	+0.29%	+5.45%	+23.55%	477M
MEDICAL IKKOU GROUP CO.,LTD.	+0.14%	+0.46%	-6.60%	+30.41%	64.94M
Average	+0.10%	-0.43%	+7.33%	+8.68%	2.01B
Weighted average by Cap.	-0.33%	-1.26%	+24.26%	-23.25%

See all sector performances

Farmaceutica Remedia SA is a Romania-based company principally engaged in the operation of pharmacies. The Company is active in the marketing, import and distribution of drugs. Additionally, it sells packing materials for pharmaceutical industry. The company operates approximately a network of 100 pharmacies and drugstores placed in Alba, Arad, Bucharest, Calarasi, Cluj, Dambovita, Dolj, Giurgiu, Hunedoara, Ilfov, Sibiu, Timis and Tulcea. Farmaceutica Remedia also operates eight logistic centers in Bucuresti, Deva, Brasov, Craiova, Iasi, Pitesti, Sibiu, Tg. Mures and Timisoara. The Companyâ€™s major shareholders are Tarus Valentin-Norbert, which owns 66.06% of shares, and AHG Vermogensverwaltungs GmbH Cottbus with 16.5%.

Employees

Sector

Drug Retailers

Calendar

08-26 Earnings release - Q2 2026

More about the company

	2024	2025
Net sales	744M 162M 142M 132M 121M 228M 15.65B 232M 1.58B 616M 7.63B 607M 593M 26.47B	761M 165M 145M 135M 124M 233M 16B 237M 1.61B 630M 7.81B 620M 607M 27.08B
Net income	6.96M 1.51M 1.33M 1.24M 1.14M 2.13M 146M 2.17M 14.77M 5.76M 71.43M 5.68M 5.55M 248M	8.04M 1.75M 1.54M 1.43M 1.31M 2.46M 169M 2.5M 17.06M 6.65M 82.47M 6.55M 6.41M 286M
Net Debt	-46.77M -10.16M -8.94M -8.3M -7.63M -14.32M -984M -14.57M -99.26M -38.72M -480M -38.14M -37.32M -1.66B	-57.19M -12.42M -10.92M -10.15M -9.33M -17.51M -1.2B -17.82M -121M -47.34M -587M -46.63M -45.62M -2.04B